Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 329 institutions reported holding it in 13F filings for Q2 2026, worth $3.72B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +8 vs. previous quarter
- 329
- 13F valueReported value at the end of Q2 2026
- $3.72B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HAE, Q2 2026
No superinvestor reported holding HAE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Haemonetics Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Kroll Mark WDirector | PPurchase | +1.40K | $70.56 | +$98.8K | +6.0%24.8K after | |
| Jul 29, 2024 (view filing) | Jul 26 | 3 days | Strong Stewart WPresident, Global Hospital | SSale | −4.31K | $91.15 | −$393.0K | −19.2%18.2K after | 10b5-1 |
| Jul 15, 2024 (view filing) | Jul 11-12 | 4 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −2.21K | $90.00 | −$199.3K | −9.4%21.3K after | 2 lots10b5-1 |
| May 29, 2024 (view filing) | May 29 | Same day | Basil Michelle LEVP and General Counsel | SSale | −13.0K | $88.08 | −$1.14M | −29.4%31.3K after | 2 lots10b5-1 |
| May 29, 2024 (view filing) | May 29 | Same day | Strong Stewart WPresident, Global Hospital | SSale | −8.86K | $87.53 | −$775.3K | −32.7%18.2K after | 10b5-1 |
| May 21, 2024 (view filing) | May 20 | 1 day | Strong Stewart WPresident, Global Hospital | SSale | −686 | $95.11 | −$65.2K | −3.6%18.2K after | 10b5-1 |
| May 21, 2024 (view filing) | May 17-20 | 4 days | Llorens JosepEVP, Global Manufacturing | SSale | −1.81K | $94.96 | −$171.8K | −7.8%21.3K after | 2 lots10b5-1 |
| May 21, 2024 (view filing) | May 17-20 | 4 days | Basil Michelle LEVP and General Counsel | SSale | −2.68K | $95.05 | −$254.4K | −7.9%31.3K after | 2 lots10b5-1 |
| May 17, 2024 (view filing) | May 16 | 1 day | Strong Stewart WPresident, Global Hospital | SSale | −733 | $96.04 | −$70.4K | −4.5%15.6K after | 10b5-1 |
| May 17, 2024 (view filing) | May 16 | 1 day | Basil Michelle LEVP and General Counsel | SSale | −985 | $96.14 | −$94.7K | −3.1%30.4K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Haemonetics Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,909,258 | $443.2M | 0.01% | +289,279+5.1% | Added |
| Neuberger Berman Group LLC | 4,179,443 | $313.5M | 0.21% | +618,525+17.4% | Added |
| Vanguard Portfolio Management LLC | 2,546,394 | $191.0M | 0.01% | −12,922−0.5% | Reduced |
| AQR Capital Management LLC | 2,266,489 | $165.0M | 0.06% | −1,090,054−32.5% | Reduced |
| Ariel Investments, LLC | 2,060,966 | $154.6M | 1.54% | +2,060,966 | New |
| Vanguard Capital Management LLC | 2,059,578 | $154.5M | 0.00% | −30,811−1.5% | Reduced |
| State Street Corp | 1,818,186 | $136.4M | 0.00% | +45,288+2.6% | Added |
| Dimensional Fund Advisors LP | 1,585,222 | $118.9M | 0.02% | +259,165+19.5% | Added |
| Citadel Advisors LLC | 1,510,120 | $113.3M | 0.07% | +1,251,967+485.0% | Added |
| Geode Capital Management, LLC | 1,287,240 | $96.6M | 0.01% | +68,262+5.6% | Added |